Afuco™ Anti-Human CDK5R1 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-CDK5R1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody binds specifically to the cyclin-dependent kinase 5 (Cdk5) activating protein, p25 and not to p35, a hybridoma cell line producing the monoclonal antibody, and the use of the monoclonal antibody is for detection and treatment of neuronal disorders and cancers.
Supplier Creative Biolabs
Product # AFC-146CL
Pricing Inquiry
Host Humanized
Target CDK5R1
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≤1 year at -20°C.
Feedback